文献速递乳房整形与再造

亚洲患者乳房假体相关间变性大细胞淋巴瘤的分子特征分析

Analysis of the Molecular Signature of Breast Implant-Associated Anaplastic Large Cell Lymphoma in an Asian Patient.
PubMed 文献 · Aesthet Surg J · 2021-01-01

本文报道韩国首例乳房假体相关间变性大细胞淋巴瘤(BIA-ALCL)病例,患者为44岁女性,有毛面假体隆乳史,表现为迟发性假体周围积液,CD30+ALK-组织学。研究对双侧乳房包膜行免疫组化及RNA测序转录组分析,发现淋巴瘤相关包膜中CD30+细胞浸润至瘤周病变,JAK/STAT3通路强激活并表达PD-L1,且以CD8+ T细胞丰富为特征,不同于高加索患者的CD4+ T细胞激活表型。

要点

  • 亚洲BIA-ALCL罕见,韩国首例表现为迟发积液和CD30+ALK-组织学。
  • 瘤周包膜亦见CD30+细胞浸润,肌纤维母细胞和血管形态与瘤区相似。
  • 亚洲病例以CD8+ T细胞丰富为特征,不同于高加索病例的CD4+ T细胞激活。

核心结论

  • 亚洲BIA-ALCL病例的分子特征与高加索患者不同,以CD8+ T细胞丰富为特点,JAK/STAT3通路强激活并表达PD-L1。

研究设计与样本

  • 个案报道:韩国首例BIA-ALCL,44岁女性,毛面假体隆乳后迟发假体周围积液,行双侧假体取出及全包膜切除。
  • 对双侧乳房包膜行免疫组化及RNA测序转录组分析,鉴定高上调基因集并表征淋巴瘤免疫细胞组分。

主要发现

  • 淋巴瘤相关包膜中CD30+细胞不仅浸润淋巴瘤病灶,也浸润瘤周病灶。
  • 瘤周病灶中肌纤维母细胞和血管形态与肿瘤病灶相似。
  • 淋巴瘤中观察到JAK/STAT3通路强激活及程序性死亡配体-1(PD-L1)表达。
  • 与高加索BIA-ALCL样本均含激活CD4+ T细胞不同,该亚洲患者以更丰富的CD8+ T细胞为特征。

临床怎么用

  • 对毛面假体隆乳后迟发假体周围积液应警惕BIA-ALCL,行CD30+ALK-免疫组化确诊。
  • 确诊后行双侧假体取出及全包膜切除,并送包膜病理及分子检测。
  • 亚洲患者分子表型以CD8+ T细胞丰富、JAK/STAT3激活及PD-L1表达为特征,可能为靶向治疗提供依据。

局限性

  • 本文为单例个案报道,结论需更多亚洲病例验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL)-a new category of anaplastic large cell lymphoma associated with textured breast implants-has a distinct variation in incidence and is especially rare in Asia. We report the first case of BIA-ALCL in Korea and present its histological and genetic characteristics. A 44-year-old female patient presented with a typical clinical course and symptoms, including breast augmentation with textured breast implants, late-onset peri-implant effusion, and CD30+ALK- histology, followed by bilateral implant removal and total capsulectomy. For histological analysis, we performed immunohistochemistry of the bilateral breast capsules. For transcriptome analysis, we identified highly upregulated gene sets employing RNA-sequencing and characterized the lymphoma immune cell components. In the lymphoma-associated capsule, CD30+ cells infiltrated not only the lymphoma lesion but also the peritumoral lesion. The morphologies of the myofibroblasts and vessels in the peritumoral lesion were similar to those in the tumoral lesion. We observed strong activation of the JAK/STAT3 pathway and expression of programmed death ligand-1 in the lymphoma. Unlike the molecular profiles of BIA-ALCL samples from Caucasian patients-all of which contained activated CD4+ T cells-the Asian patient's profile was characterized by more abundant CD8+ T cells. This study contributes to a better understanding of the pathogenesis and molecular mechanisms of BIA-ALCL in Asian patients that will ultimately facilitate the development of clinical therapies.

来源:Aesthet Surg J,查看原文。版权归原作者所有。

引用

  1. Kim IK, Hong KY, Lee CK, et al. Analysis of the Molecular Signature of Breast Implant-Associated Anaplastic Large Cell Lymphoma in an Asian Patient. Aesthet Surg J. 2021. PMID: 33367520. doi:10.1093/asj/sjaa398

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。